跳至主要内容
临床试验/NCT06796673
NCT06796673Enrolling By Invitation不适用

Retina BioBank: Retina Biomarkers for a Deeper Understanding of Vitreoretinal and Systemic Diseases

Greater Houston Retina Research1 个研究点 分布在 1 个国家目标入组 10,000 人开始时间: 2022年4月11日最近更新:

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
10,000
试验地点
1
主要终点
To quantify levels of disease state biomarkers implicated in the pathogenesis of various retinal and systemic pathologies

研究概览

简要总结

The RBBK study is a non-interventional, prospective study that will characterize disease state biomarker levels from aqueous humor, vitreous humor, intraoperative tissue and saliva of subjects with various retinal and systemic pathologies.

详细描述

The RBBK study is a non-interventional, prospective study that will characterize disease state biomarker levels from aqueous humor, vitreous humor, intraoperative tissue and saliva of subjects with various retinal and systemic pathologies.

Participants are eligible to be included in the study only if all of the following criteria apply:

  1. Men or women > 18 years of age
  2. Subjects with vitreoretinal disease in at least one eye receiving a retinal treatment intervention
  3. Able and willing to provide signed informed consent

The study will consist of a single visit and a retrospective chart review. The study visit will consist of:

  1. Screening for eligibility;
  2. Aqueous humor collection (if applicable);
  3. Vitreous humor collection (if applicable);
  4. Intraoperative tissue (if applicable); and
  5. Saliva collection

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects with vitreoretinal disease in at least one eye receiving a retinal treatment intervention

排除标准

  • Prior intraocular or subtenon steroid injection in the study eye within the prior 1 month of signing informed consent
  • Intraocular or refractive surgery in the study eye within 30 days of signing informed consent
  • Systemic anti-VEGF treatment within 90 days of signing informed consent

结局指标

主要结局

To quantify levels of disease state biomarkers implicated in the pathogenesis of various retinal and systemic pathologies

时间窗: Baseline

An analysis of the ocular fluids and tissues of patients with various vitreoretinal diseases would allow for the development of a deeper understanding of the processes that contribute to their onset and may ultimately provide insight in methods to refine treatment and management options.

次要结局

未报告次要终点

研究者

发起方
Greater Houston Retina Research
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验